coronavirus covid-19 sars-cov-2 illustration

CORONAVIRUS RESEARCH

Georgia State scientists are unraveling how the coronavirus operates, searching for effective treatments and diving into the pandemic’s impact on the economy and society. Learn more below about how our research community is making a difference.

ADDITIONAL RESOURCES

CORONAVIRUS EXPERTS GUIDE CORONAVIRUS NEWS HUB

Research Science Center building on Georgia State University's campus

BRINGING FORWARD A NEW ANTIVIRAL TREATMENT

Georgia State scientists were the first to demonstrate that molnupiravir was orally active against SARS-CoV-2. The antiviral drug has been recommended for emergency use authorization to treat COVID-19.

INCREASING VACCINE UPTAKE

With a grant from the CDC, Georgia State’s Prevention Research Center is working to increase COVID-19 vaccination rates among refugees and other groups in Clarkston — one of the largest refugee resettlement communities in the U.S.

LEARN MORE

USING SOCIAL MEDIA TO MAP DISEASE

Juan Banda, assistant professor in the Department of Computer Science, is tapping into Twitter data to learn more about people’s experiences during the pandemic.

LEARN MORE

PROTECTING THE VULNERABLE

Georgia State researchers are teaming up with their colleagues at Emory School of Medicine to help nursing homes mitigate the impact of COVID-19 and stop the spread of SARS-CoV-2.

Tackling Emerging Viruses

Published October 21, 2021 in Georgia State News Hub

Caroline Williams earned her Ph.D. in Translational Biomedical Sciences by embarking upon studies of two newly emerging viruses, SARS-CoV-2, the virus that causes COVID-19, and Mengla virus, a newly identified filovirus.

Georgia State Recognized in White House Press Briefing for Contribution to Research on Antiviral Drug Recommended to Treat COVID-19

Published October 8, 2021 in Georgia State News Hub

Georgia State University was highlighted in a press briefing Oct. 6 by the White House COVID-19 response team, which recognized the university’s contribution to groundbreaking research that led to the development of molnupiravir.

Oral Drug Tested at Georgia State Recommended for Emergency Use Authorization to Treat COVID-19

Published October 1, 2021 in Georgia State News Hub

A new antiviral drug tested in the Institute for Biomedical Sciences at Georgia State against influenza virus and SARS-CoV-2 has been recommended for emergency use authorization to treat COVID-19 in the United States by pharmaceutical companies that completed a Phase 3 clinical trial and achieved promising results.

MORE CORONAVIRUS RESEARCH NEWS

Team Up With Our Researchers

Interested in collaborating with Georgia State scientists on coronavirus research? Contact our Office of Technology Transfer and Commercialization.

Subscribe To Our Newsletter

Subscribe to our research magazine and monthly e-newsletter and see how we’re making discoveries #THESTATEWAY^®

Contact Us

Timothy L. Denning
Vice President for Research and Economic Development
tdenning@gsu.edu

Jennifer Rainey Marquez
Associate Communications Director
jmarquez@gsu.edu

Research Administration
404-413-3500
research@gsu.edu

University Research